US FDA Draft Pre-Market Guidance Comments

Today, Apraciti submitted comments to the Federal eRulemaking Portal ( on the US Food and Drug Administrations (FDA) draft guidance, Content of Premarket Submissions for Management of Cybersecurity in Medical Devices. We continue to be encouraged by the FDA's efforts on this topic and the positive impact to the safety and security of medical devices. Read our full comments here -

Colin Morgan